Optimal duration of extended letrozole treatment after 5 years of adjuvant endocrine therapy; results of the randomized phase III IDEAL trial (BOOG 2006–05). (February 2017) - Van de Velde, C.J.H.; Blok, E.; Meershoek-Klein Kranenbarg, E.; Putter, H.; Van den Bosch, J.; Maartense, E.; Duijm-de Carpentier, M.; Van Leeuwen-Stok, E.; Liefers, G.J.; Nortier, J.; Rutgers, E.; Kroep, J.